世界の胸腺がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Thymic Carcinoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-6040
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、胸腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベリノスタット、パシレオチドER、ミルシクリブ、TLC-388、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・胸腺がん治療の市場動向
・企業の競争状況、市場シェア
・胸腺がん治療の種類別市場規模と予測2016-2027（ベリノスタット、パシレオチドER、ミルシクリブ、TLC-388、その他）
・胸腺がん治療の用途別市場規模と予測2016-2027（クリニック、病院、その他）
・胸腺がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・胸腺がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・胸腺がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・胸腺がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・胸腺がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Merck & Co., Inc.、Novartis AG、Onxeo SA、Sumitomo Dainippon Pharma Co., Ltd.、Taiwan Liposome Company, Ltd.、Tiziana Life Sciences Plc）
・結論

Market Analysis and Insights: Global Thymic Carcinoma Treatment Market
The global Thymic Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Thymic Carcinoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Thymic Carcinoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Thymic Carcinoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Thymic Carcinoma Treatment market.

Global Thymic Carcinoma Treatment Scope and Market Size
Thymic Carcinoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Thymic Carcinoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Belinostat
Pasireotide ER
Milciclib
TLC-388
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck & Co., Inc.
Novartis AG
Onxeo SA
Sumitomo Dainippon Pharma Co., Ltd.
Taiwan Liposome Company, Ltd.
Tiziana Life Sciences Plc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Thymic Carcinoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Belinostat
1.2.3 Pasireotide ER
1.2.4 Milciclib
1.2.5 TLC-388
1.2.6 Others
1.3 Market by Application
1.3.1 Global Thymic Carcinoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Thymic Carcinoma Treatment Market Perspective (2016-2027)
2.2 Thymic Carcinoma Treatment Growth Trends by Regions
2.2.1 Thymic Carcinoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Thymic Carcinoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Thymic Carcinoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Thymic Carcinoma Treatment Industry Dynamic
2.3.1 Thymic Carcinoma Treatment Market Trends
2.3.2 Thymic Carcinoma Treatment Market Drivers
2.3.3 Thymic Carcinoma Treatment Market Challenges
2.3.4 Thymic Carcinoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Thymic Carcinoma Treatment Players by Revenue
3.1.1 Global Top Thymic Carcinoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Thymic Carcinoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Thymic Carcinoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Thymic Carcinoma Treatment Revenue
3.4 Global Thymic Carcinoma Treatment Market Concentration Ratio
3.4.1 Global Thymic Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Thymic Carcinoma Treatment Revenue in 2020
3.5 Thymic Carcinoma Treatment Key Players Head office and Area Served
3.6 Key Players Thymic Carcinoma Treatment Product Solution and Service
3.7 Date of Enter into Thymic Carcinoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Thymic Carcinoma Treatment Breakdown Data by Type
4.1 Global Thymic Carcinoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Thymic Carcinoma Treatment Forecasted Market Size by Type (2022-2027)

5 Thymic Carcinoma Treatment Breakdown Data by Application
5.1 Global Thymic Carcinoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Thymic Carcinoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Thymic Carcinoma Treatment Market Size (2016-2027)
6.2 North America Thymic Carcinoma Treatment Market Size by Type
6.2.1 North America Thymic Carcinoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Thymic Carcinoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Thymic Carcinoma Treatment Market Size by Type (2016-2027)
6.3 North America Thymic Carcinoma Treatment Market Size by Application
6.3.1 North America Thymic Carcinoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Thymic Carcinoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Thymic Carcinoma Treatment Market Size by Application (2016-2027)
6.4 North America Thymic Carcinoma Treatment Market Size by Country
6.4.1 North America Thymic Carcinoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Thymic Carcinoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Thymic Carcinoma Treatment Market Size (2016-2027)
7.2 Europe Thymic Carcinoma Treatment Market Size by Type
7.2.1 Europe Thymic Carcinoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Thymic Carcinoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Thymic Carcinoma Treatment Market Size by Type (2016-2027)
7.3 Europe Thymic Carcinoma Treatment Market Size by Application
7.3.1 Europe Thymic Carcinoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Thymic Carcinoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Thymic Carcinoma Treatment Market Size by Application (2016-2027)
7.4 Europe Thymic Carcinoma Treatment Market Size by Country
7.4.1 Europe Thymic Carcinoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Thymic Carcinoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Thymic Carcinoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Thymic Carcinoma Treatment Market Size by Type
8.2.1 Asia-Pacific Thymic Carcinoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Thymic Carcinoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Thymic Carcinoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Thymic Carcinoma Treatment Market Size by Application
8.3.1 Asia-Pacific Thymic Carcinoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Thymic Carcinoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Thymic Carcinoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Thymic Carcinoma Treatment Market Size by Region
8.4.1 Asia-Pacific Thymic Carcinoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Thymic Carcinoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Thymic Carcinoma Treatment Market Size (2016-2027)
9.2 Latin America Thymic Carcinoma Treatment Market Size by Type
9.2.1 Latin America Thymic Carcinoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Thymic Carcinoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Thymic Carcinoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Thymic Carcinoma Treatment Market Size by Application
9.3.1 Latin America Thymic Carcinoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Thymic Carcinoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Thymic Carcinoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Thymic Carcinoma Treatment Market Size by Country
9.4.1 Latin America Thymic Carcinoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Thymic Carcinoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Thymic Carcinoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Thymic Carcinoma Treatment Market Size by Type
10.2.1 Middle East & Africa Thymic Carcinoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Thymic Carcinoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Thymic Carcinoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Thymic Carcinoma Treatment Market Size by Application
10.3.1 Middle East & Africa Thymic Carcinoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Thymic Carcinoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Thymic Carcinoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Thymic Carcinoma Treatment Market Size by Country
10.4.1 Middle East & Africa Thymic Carcinoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Thymic Carcinoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Details
11.1.2 Merck & Co., Inc. Business Overview
11.1.3 Merck & Co., Inc. Thymic Carcinoma Treatment Introduction
11.1.4 Merck & Co., Inc. Revenue in Thymic Carcinoma Treatment Business (2016-2021)
11.1.5 Merck & Co., Inc. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Thymic Carcinoma Treatment Introduction
11.2.4 Novartis AG Revenue in Thymic Carcinoma Treatment Business (2016-2021)
11.2.5 Novartis AG Recent Development
11.3 Onxeo SA
11.3.1 Onxeo SA Company Details
11.3.2 Onxeo SA Business Overview
11.3.3 Onxeo SA Thymic Carcinoma Treatment Introduction
11.3.4 Onxeo SA Revenue in Thymic Carcinoma Treatment Business (2016-2021)
11.3.5 Onxeo SA Recent Development
11.4 Sumitomo Dainippon Pharma Co., Ltd.
11.4.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details
11.4.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
11.4.3 Sumitomo Dainippon Pharma Co., Ltd. Thymic Carcinoma Treatment Introduction
11.4.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Thymic Carcinoma Treatment Business (2016-2021)
11.4.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development
11.5 Taiwan Liposome Company, Ltd.
11.5.1 Taiwan Liposome Company, Ltd. Company Details
11.5.2 Taiwan Liposome Company, Ltd. Business Overview
11.5.3 Taiwan Liposome Company, Ltd. Thymic Carcinoma Treatment Introduction
11.5.4 Taiwan Liposome Company, Ltd. Revenue in Thymic Carcinoma Treatment Business (2016-2021)
11.5.5 Taiwan Liposome Company, Ltd. Recent Development
11.6 Tiziana Life Sciences Plc
11.6.1 Tiziana Life Sciences Plc Company Details
11.6.2 Tiziana Life Sciences Plc Business Overview
11.6.3 Tiziana Life Sciences Plc Thymic Carcinoma Treatment Introduction
11.6.4 Tiziana Life Sciences Plc Revenue in Thymic Carcinoma Treatment Business (2016-2021)
11.6.5 Tiziana Life Sciences Plc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Thymic Carcinoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Belinostat
Table 3. Key Players of Pasireotide ER
Table 4. Key Players of Milciclib
Table 5. Key Players of TLC-388
Table 6. Key Players of Others
Table 7. Global Thymic Carcinoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Thymic Carcinoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Thymic Carcinoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Thymic Carcinoma Treatment Market Share by Regions (2016-2021)
Table 11. Global Thymic Carcinoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Thymic Carcinoma Treatment Market Share by Regions (2022-2027)
Table 13. Thymic Carcinoma Treatment Market Trends
Table 14. Thymic Carcinoma Treatment Market Drivers
Table 15. Thymic Carcinoma Treatment Market Challenges
Table 16. Thymic Carcinoma Treatment Market Restraints
Table 17. Global Thymic Carcinoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Thymic Carcinoma Treatment Market Share by Players (2016-2021)
Table 19. Global Top Thymic Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thymic Carcinoma Treatment as of 2020)
Table 20. Ranking of Global Top Thymic Carcinoma Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Thymic Carcinoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Thymic Carcinoma Treatment Product Solution and Service
Table 24. Date of Enter into Thymic Carcinoma Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Thymic Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Thymic Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Thymic Carcinoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Thymic Carcinoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Thymic Carcinoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Thymic Carcinoma Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Thymic Carcinoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Thymic Carcinoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Thymic Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Thymic Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Thymic Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Thymic Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Thymic Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Thymic Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Thymic Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Thymic Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Thymic Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Thymic Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Thymic Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Thymic Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Thymic Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Thymic Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Thymic Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Thymic Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Thymic Carcinoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Thymic Carcinoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Thymic Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Thymic Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Thymic Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Thymic Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Thymic Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Thymic Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Thymic Carcinoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Thymic Carcinoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Thymic Carcinoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Thymic Carcinoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Thymic Carcinoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Thymic Carcinoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Merck & Co., Inc. Company Details
Table 65. Merck & Co., Inc. Business Overview
Table 66. Merck & Co., Inc. Thymic Carcinoma Treatment Product
Table 67. Merck & Co., Inc. Revenue in Thymic Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 68. Merck & Co., Inc. Recent Development
Table 69. Novartis AG Company Details
Table 70. Novartis AG Business Overview
Table 71. Novartis AG Thymic Carcinoma Treatment Product
Table 72. Novartis AG Revenue in Thymic Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 73. Novartis AG Recent Development
Table 74. Onxeo SA Company Details
Table 75. Onxeo SA Business Overview
Table 76. Onxeo SA Thymic Carcinoma Treatment Product
Table 77. Onxeo SA Revenue in Thymic Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 78. Onxeo SA Recent Development
Table 79. Sumitomo Dainippon Pharma Co., Ltd. Company Details
Table 80. Sumitomo Dainippon Pharma Co., Ltd. Business Overview
Table 81. Sumitomo Dainippon Pharma Co., Ltd. Thymic Carcinoma Treatment Product
Table 82. Sumitomo Dainippon Pharma Co., Ltd. Revenue in Thymic Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 83. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 84. Taiwan Liposome Company, Ltd. Company Details
Table 85. Taiwan Liposome Company, Ltd. Business Overview
Table 86. Taiwan Liposome Company, Ltd. Thymic Carcinoma Treatment Product
Table 87. Taiwan Liposome Company, Ltd. Revenue in Thymic Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 88. Taiwan Liposome Company, Ltd. Recent Development
Table 89. Tiziana Life Sciences Plc Company Details
Table 90. Tiziana Life Sciences Plc Business Overview
Table 91. Tiziana Life Sciences Plc Thymic Carcinoma Treatment Product
Table 92. Tiziana Life Sciences Plc Revenue in Thymic Carcinoma Treatment Business (2016-2021) & (US$ Million)
Table 93. Tiziana Life Sciences Plc Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Thymic Carcinoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Belinostat Features
Figure 3. Pasireotide ER Features
Figure 4. Milciclib Features
Figure 5. TLC-388 Features
Figure 6. Others Features
Figure 7. Global Thymic Carcinoma Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Thymic Carcinoma Treatment Report Years Considered
Figure 12. Global Thymic Carcinoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Thymic Carcinoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Thymic Carcinoma Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Thymic Carcinoma Treatment Market Share by Regions (2022-2027)
Figure 16. Global Thymic Carcinoma Treatment Market Share by Players in 2020
Figure 17. Global Top Thymic Carcinoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thymic Carcinoma Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Thymic Carcinoma Treatment Revenue in 2020
Figure 19. Global Thymic Carcinoma Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Thymic Carcinoma Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Thymic Carcinoma Treatment Market Share by Type (2016-2027)
Figure 23. North America Thymic Carcinoma Treatment Market Share by Application (2016-2027)
Figure 24. North America Thymic Carcinoma Treatment Market Share by Country (2016-2027)
Figure 25. United States Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Thymic Carcinoma Treatment Market Share by Type (2016-2027)
Figure 29. Europe Thymic Carcinoma Treatment Market Share by Application (2016-2027)
Figure 30. Europe Thymic Carcinoma Treatment Market Share by Country (2016-2027)
Figure 31. Germany Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Thymic Carcinoma Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Thymic Carcinoma Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Thymic Carcinoma Treatment Market Share by Region (2016-2027)
Figure 41. China Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Thymic Carcinoma Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Thymic Carcinoma Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Thymic Carcinoma Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Thymic Carcinoma Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Thymic Carcinoma Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Thymic Carcinoma Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Thymic Carcinoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Merck & Co., Inc. Revenue Growth Rate in Thymic Carcinoma Treatment Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Thymic Carcinoma Treatment Business (2016-2021)
Figure 62. Onxeo SA Revenue Growth Rate in Thymic Carcinoma Treatment Business (2016-2021)
Figure 63. Sumitomo Dainippon Pharma Co., Ltd. Revenue Growth Rate in Thymic Carcinoma Treatment Business (2016-2021)
Figure 64. Taiwan Liposome Company, Ltd. Revenue Growth Rate in Thymic Carcinoma Treatment Business (2016-2021)
Figure 65. Tiziana Life Sciences Plc Revenue Growth Rate in Thymic Carcinoma Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界のハースル細胞がん治療市場規模・現状・予測（2021年-2027年）

Global Hurthle Cell Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4335 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、ハースル細胞がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一般外科、甲状腺全摘、ロボット支援手術、放射性ヨウ素（RAI）、その他）、用途別市場規模（病院、外科医院、クリニック、その他）、主要...

世界の内分泌癌治療市場規模・現状・予測（2021年-2027年）

Global Neuroendocrine Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4566 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、内分泌癌治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ソマトスタチン類似体、標的療法、化学療法）、用途別市場規模（病院、クリニック、オンコロジーセンター、外来手術センター、その他）、主要地域別市...

世界の皮膚扁平上皮がん治療市場規模・現状・予測（2021年-2027年）

Global Cutaneous Squamous Cell Carcinoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4084 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、皮膚扁平上皮がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、非外科的治療）、用途別市場規模（病院、がん研究所、外来外科センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の副腎皮質がん用治療薬市場規模・現状・予測（2021年-2027年）

Global Adrenocortical Carcinoma Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5567 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、副腎皮質がん用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法）、用途別市場規模（病院、研究機関、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の子宮内膜癌分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Endometrial Carcinoma Market Size, Status and Forecast 2021-2027
QFJ1-4515 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、子宮内膜癌分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米...

世界の鼻咽頭癌分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Nasopharyngeal Carcinoma Market Size, Status and Forecast 2021-2027
QFJ1-4520 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、鼻咽頭癌分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の内分泌癌治療薬市場規模・現状・予測（2021年-2027年）

Global Neuroendocrine Carcinoma Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5880 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、内分泌癌治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ソマトスタチン類似体、標的療法薬、化学療法薬）、用途別市場規模（病院、クリニック、オンコロジーセンター、外来手術センター）、主要地域別市場...

世界の腎臓癌＆腎細胞癌（RCC）治療薬市場規模・現状・予測（2021年-2027年）

Global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5819 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、腎臓癌＆腎細胞癌（RCC）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アフィニトール（エベロリムス）、アバスチン（ベバシズマブ）、カボメティ（カボザンチニブ）、インリタ（アキシチニブ）、ネク...

世界の腎細胞がん臨床試験パイプライン市場規模・現状・予測（2021年-2027年）

Global Renal Cell Carcinoma Clinical Trial Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4808 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、腎細胞がん臨床試験パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法）、用途別市場規模（病院、研究所、商業、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のハースル細胞がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hurthle Cell Carcinoma Treatment Market The global Hurthle Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
世界の内分泌癌治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Neuroendocrine Carcinoma Treatment Market The global Neuroendocrine Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の皮膚扁平上皮がん治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cutaneous Squamous Cell Carcinoma Treatment Market The global Cutaneous Squamous Cell Carcinoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in …
世界の副腎皮質がん用治療薬市場規模・現状・予測（2021年-2027年） The adrenocortical carcinoma drugs market has recorded the development of several advanced imaging techniques, which are non-invasive and exhibit enhanced diagnostic accuracy in the detection of adrenal lesions. For instance, unenhanced computed tomography adrenal densitometry is used to differentia…
世界の子宮内膜癌分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing endometrial carcinoma Market Analysis and Insights: Global Molecular Diagnosis of Endometrial Carcinoma Market The global Molecular Diagnosis of Endometrial Carcinoma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% durin…